ArticleBlood advances2026

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.